Endothelial cell junctional adhesion molecules

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 36, Issue 10, 2016, Pages 2048-2057

  Reglero Real, Natalia ^a   Colom, Bartomeu ^a,b   Bodkin, Jennifer Victoria ^a   Nourshargh, Sussan ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

adhesion molecule; blood vessel; endothelial cell; inflammation; vascular permeability

Indexed keywords

CD31 ANTIGEN; JUNCTIONAL ADHESION MOLECULE; JUNCTIONAL ADHESION MOLECULE A; JUNCTIONAL ADHESION MOLECULE C; VASCULAR ENDOTHELIAL CADHERIN;

ARTICLE; BLOOD VESSEL; CELL SURFACE; CHRONIC INFLAMMATION; DYNAMICS; ENDOTHELIUM CELL; HUMAN; INFLAMMATION; INTERNALIZATION; LEUKOCYTE; MACROMOLECULE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; ANIMAL; CAPILLARY PERMEABILITY; CELL JUNCTION; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; PROTEIN PROCESSING; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

ANIMALS; CAPILLARY PERMEABILITY; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INTERCELLULAR JUNCTIONS; JUNCTIONAL ADHESION MOLECULES; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

EID: 84981736578     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.116.307610     Document Type: Article

References (78)

1. Dejana E, Tournier-Lasserve E, Weinstein BM. The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications. Dev Cell. 2009;16:209-221. doi: 10.1016/j. devcel.2009.01.004.
2. Nourshargh S, Hordijk PL, Sixt M. Breaching multiple barriers: leukocyte motility through venular walls and the interstitium. Nat Rev Mol Cell Biol. 2010;11:366-378. doi: 10.1038/nrm2889.
3. Vestweber D. How leukocytes cross the vascular endothelium. Nat Rev Immunol. 2015;15:692-704. doi: 10.1038/nri3908.
4. Muller WA. Localized signals that regulate transendothelial migration. Curr Opin Immunol. 2016;38:24-29. doi: 10.1016/j.coi.2015.10.006.
5. Giannotta M, Trani M, Dejana E. VE-cadherin and endothelial adherens junctions: active guardians of vascular integrity. Dev Cell. 2013;26:441-454. doi: 10.1016/j.devcel.2013.08.020.
6. Nourshargh S, Alon R. Leukocyte migration into inflamed tissues. Immunity. 2014;41:694-707. doi: 10.1016/j.immuni.2014.10.008.
7. Ley K, Laudanna C, Cybulsky MI, Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol. 2007;7:678-689. doi: 10.1038/nri2156.
8. Engelhardt B, Ransohoff RM. Capture, crawl, cross: the T cell code to breach the blood-brain barriers. Trends Immunol. 2012;33:579-589. doi: 10.1016/j.it.2012.07.004.
9. Woodfin A, Voisin MB, Beyrau M, Colom B, Caille D, Diapouli FM, Nash GB, Chavakis T, Albelda SM, Rainger GE, Meda P, Imhof BA, Nourshargh S. The junctional adhesion molecule JAM-C regulates polarized transendothelial migration of neutrophils in vivo. Nat Immunol. 2011;12:761-769. doi: 10.1038/ni.2062.
10. Schulte D, Küppers V, Dartsch N, Broermann A, Li H, Zarbock A, Kamenyeva O, Kiefer F, Khandoga A, Massberg S, Vestweber D. Stabilizing the VE-cadherin-catenin complex blocks leukocyte extravasation and vascular permeability. EMBO J. 2011;30:4157-4170. doi: 10.1038/emboj.2011.304.
11. Gerhardt T, Ley K. Monocyte trafficking across the vessel wall. Cardiovasc Res. 2015;107:321-330. doi: 10.1093/cvr/cvv147.
12. Hickey MJ, Westhorpe CL. Imaging inflammatory leukocyte recruitment in kidney, lung and liver-challenges to the multi-step paradigm. Immunol Cell Biol. 2013;91:281-289. doi: 10.1038/icb.2012.83.
13. DiStasi MR, Ley K. Opening the flood-gates: how neutrophil-endothelial interactions regulate permeability. Trends Immunol. 2009;30:547-556. doi: 10.1016/j.it.2009.07.012.
14. Finsterbusch M, Voisin MB, Beyrau M, Williams TJ, Nourshargh S. Neutrophils recruited by chemoattractants in vivo induce microvascular plasma protein leakage through secretion of TNF. J Exp Med. 2014;211:1307-1314. doi: 10.1084/jem.20132413.
15. Schnoor M, Lai FP, Zarbock A, Kläver R, Polaschegg C, Schulte D, Weich HA, Oelkers JM, Rottner K, Vestweber D. Cortactin deficiency is associated with reduced neutrophil recruitment but increased vascular permeability in vivo. J Exp Med. 2011;208:1721-1735. doi: 10.1084/jem.20101920.
16. Wessel F, Winderlich M, Holm M, Frye M, Rivera-Galdos R, Vockel M, Linnepe R, Ipe U, Stadtmann A, Zarbock A, Nottebaum AF, Vestweber D. Leukocyte extravasation and vascular permeability are each controlled in vivo by different tyrosine residues of VE-cadherin. Nat Immunol. 2014;15:223-230. doi: 10.1038/ni.2824.
17. Vestweber D. Relevance of endothelial junctions in leukocyte extravasation and vascular permeability. Ann N Y Acad Sci. 2012;1257:184-192. doi: 10.1111/j.1749-6632.2012.06558.x.
18. Broermann A, Winderlich M, Block H, Frye M, Rossaint J, Zarbock A, Cagna G, Linnepe R, Schulte D, Nottebaum AF, Vestweber D. Dissociation of VE-PTP from VE-cadherin is required for leukocyte extravasation and for VEGF-induced vascular permeability in vivo. J Exp Med. 2011;208:2393-2401. doi: 10.1084/jem.20110525.
19. Luissint AC, Nusrat A, Parkos CA. JAM-related proteins in mucosal homeostasis and inflammation. Semin Immunopathol. 2014;36:211-226. doi: 10.1007/s00281-014-0421-0.
20. Orlova VV, Economopoulou M, Lupu F, Santoso S, Chavakis T. Junctional adhesion molecule-C regulates vascular endothelial permeability by modulating VE-cadherin-mediated cell-cell contacts. J Exp Med. 2006;203:2703-2714. doi: 10.1084/jem.20051730.
21. Ballet R, Emre Y, Jemelin S, Charmoy M, Tacchini-Cottier F, Imhof BA. Blocking junctional adhesion molecule C enhances dendritic cell migration and boosts the immune responses against Leishmania major. PLoS Pathog. 2014;10:e1004550. doi: 10.1371/journal.ppat.1004550.
22. Wegmann F, Petri B, Khandoga AG, Moser C, Khandoga A, Volkery S, Li H, Nasdala I, Brandau O, Fässler R, Butz S, Krombach F, Vestweber D. ESAM supports neutrophil extravasation, activation of Rho, and VEGFinduced vascular permeability. J Exp Med. 2006;203:1671-1677. doi: 10.1084/jem.20060565.
23. Ozaki H, Ishii K, Horiuchi H, Arai H, Kawamoto T, Okawa K, Iwamatsu A, Kita T. Cutting edge: combined treatment of TNF-Alpha and IFNgamma causes redistribution of junctional adhesion molecule in human endothelial cells. J Immunol. 1999;163:553-557.
24. Rival Y, Del Maschio A, Rabiet MJ, Dejana E, Duperray A. Inhibition of platelet endothelial cell adhesion molecule-1 synthesis and leukocyte transmigration in endothelial cells by the combined action of TNF-Alpha and IFN-gamma. J Immunol. 1996;157:1233-1241.
25. Shaw SK, Perkins BN, Lim YC, Liu Y, Nusrat A, Schnell FJ, Parkos CA, Luscinskas FW. Reduced expression of junctional adhesion molecule and platelet/endothelial cell adhesion molecule-1 (CD31) at human vascular endothelial junctions by cytokines tumor necrosis factor-Alpha plus interferon-gamma Does not reduce leukocyte transmigration under flow. Am J Pathol. 2001;159:2281-2291.
26. Stewart RJ, Kashour TS, Marsden PA. Vascular endothelial platelet endothelial adhesion molecule-1 (PECAM-1) expression is decreased by TNFalpha and IFN-gamma. Evidence for cytokine-induced destabilization of messenger ribonucleic acid transcripts in bovine endothelial cells. J Immunol. 1996;156:1221-1228.
27. Alcaide P, Newton G, Auerbach S, Sehrawat S, Mayadas TN, Golan DE, Yacono P, Vincent P, Kowalczyk A, Luscinskas FW. p120-Catenin regulates leukocyte transmigration through an effect on VE-cadherin phosphorylation. Blood. 2008;112:2770-2779. doi: 10.1182/blood-2008-03-147181.
28. Allport JR, Muller WA, Luscinskas FW. Monocytes induce reversible focal changes in vascular endothelial cadherin complex during transendothelial migration under flow. J Cell Biol. 2000;148:203-216.
29. Shaw SK, Bamba PS, Perkins BN, Luscinskas FW. Real-Time imaging of vascular endothelial-cadherin during leukocyte transmigration across endothelium. J Immunol. 2001;167:2323-2330.
30. Gavard J, Gutkind JS. VEGF controls endothelial-cell permeability by promoting the beta-Arrestin-dependent endocytosis of VE-cadherin. Nat Cell Biol. 2006;8:1223-1234. doi: 10.1038/ncb1486.
31. Naik MU, Mousa SA, Parkos CA, Naik UP. Signaling through JAM-1 and alphavbeta3 is required for the angiogenic action of bFGF: dissociation of the JAM-1 and alphavbeta3 complex. Blood. 2003;102:2108-2114. doi: 10.1182/blood-2003-04-1114.
32. Schmitt MM, Fraemohs L, Hackeng TM, Weber C, Koenen RR. Atherogenic mononuclear cell recruitment is facilitated by oxidized lipoprotein-induced endothelial junctional adhesion molecule-A redistribution. Atherosclerosis. 2014;234:254-264. doi: 10.1016/j. atherosclerosis.2014.03.014.
33. Keiper T, Al-Fakhri N, Chavakis E, Athanasopoulos AN, Isermann B, Herzog S, Saffrich R, Hersemeyer K, Bohle RM, Haendeler J, Preissner KT, Santoso S, Chavakis T. The role of junctional adhesion molecule-C (JAM-C) in oxidized LDL-mediated leukocyte recruitment. FASEB J. 2005;19:2078-2080. doi: 10.1096/fj.05-4196fje.
34. Li X, Stankovic M, Lee BP, Aurrand-Lions M, Hahn CN, Lu Y, Imhof BA, Vadas MA, Gamble JR. JAM-C induces endothelial cell permeability through its association and regulation of {beta}3 integrins. Arterioscler Thromb Vasc Biol. 2009;29:1200-1206. doi: 10.1161/ATVBAHA.109.189217.
35. Ostermann G, Fraemohs L, Baltus T, Schober A, Lietz M, Zernecke A, Liehn EA, Weber C. Involvement of JAM-A in mononuclear cell recruitment on inflamed or atherosclerotic endothelium: inhibition by soluble JAM-A. Arterioscler Thromb Vasc Biol. 2005;25:729-735. doi: 10.1161/01.ATV.0000157154.14474.3b.
36. Babinska A, Azari BM, Salifu MO, Liu R, Jiang XC, Sobocka MB, Boo D, Al Khoury G, Deitch JS, Marmur JD, Ehrlich YH, Kornecki E. The F11 receptor (F11R/JAM-A) in atherothrombosis: overexpression of F11R in atherosclerotic plaques. Thromb Haemost. 2007;97:272-281.
37. Schmitt MM, Megens RT, Zernecke A, Bidzhekov K, van den Akker NM, Rademakers T, van Zandvoort MA, Hackeng TM, Koenen RR, Weber C. Endothelial junctional adhesion molecule-A guides monocytes into flowdependent predilection sites of atherosclerosis. Circulation. 2014;129:66-76. doi: 10.1161/CIRCULATIONAHA.113.004149.
38. Khandoga A, Kessler JS, Meissner H, Hanschen M, Corada M, Motoike T, Enders G, Dejana E, Krombach F. Junctional adhesion molecule-A deficiency increases hepatic ischemia-reperfusion injury despite reduction of neutrophil transendothelial migration. Blood. 2005;106:725-733. doi: 10.1182/blood-2004-11-4416.
39. Rabquer BJ, Pakozdi A, Michel JE, Gujar BS, Haines GK III, Imhof BA, Koch AE. Junctional adhesion molecule C mediates leukocyte adhesion to rheumatoid arthritis synovium. Arthritis Rheum. 2008;58:3020-3029. doi: 10.1002/art.23867.
40. Scheiermann C, Colom B, Meda P, Patel NS, Voisin MB, Marrelli A, Woodfin A, Pitzalis C, Thiemermann C, Aurrand-Lions M, Imhof BA, Nourshargh S. Junctional adhesion molecule-C mediates leukocyte infiltration in response to ischemia reperfusion injury. Arterioscler Thromb Vasc Biol. 2009;29:1509-1515. doi: 10.1161/ATVBAHA.109.187559.
41. Colom B, Bodkin JV, Beyrau M, Woodfin A, Ody C, Rourke C, Chavakis T, Brohi K, Imhof BA, Nourshargh S. Leukotriene B4-Neutrophil Elastase Axis Drives Neutrophil Reverse Transendothelial Cell Migration In Vivo. Immunity. 2015;42:1075-1086. doi: 10.1016/j.immuni.2015.05.010.
42. Lamagna C, Meda P, Mandicourt G, Brown J, Gilbert RJ, Jones EY, Kiefer F, Ruga P, Imhof BA, Aurrand-Lions M. Dual interaction of JAM-C with JAM-B and alpha(M)beta2 integrin: function in junctional complexes and leukocyte adhesion. Mol Biol Cell. 2005;16:4992-5003. doi: 10.1091/mbc.E05-04-0310.
43. Ilan N, Mohsenin A, Cheung L, Madri JA. PECAM-1 shedding during apoptosis generates a membrane-Anchored truncated molecule with unique signaling characteristics. FASEB J. 2001;15:362-372. doi: 10.1096/fj.00-0372com.
44. Hermant B, Bibert S, Concord E, Dublet B, Weidenhaupt M, Vernet T, Gulino-Debrac D. Identification of proteases involved in the proteolysis of vascular endothelium cadherin during neutrophil transmigration. J Biol Chem. 2003;278:14002-14012. doi: 10.1074/jbc.M300351200.
45. Schulz B, Pruessmeyer J, Maretzky T, Ludwig A, Blobel CP, Saftig P, Reiss K. ADAM10 regulates endothelial permeability and T-Cell transmigration by proteolysis of vascular endothelial cadherin. Circ Res. 2008;102:1192-1201. doi: 10.1161/CIRCRESAHA.107.169805.
46. Xiao K, Allison DF, Buckley KM, Kottke MD, Vincent PA, Faundez V, Kowalczyk AP. Cellular levels of p120 catenin function as a set point for cadherin expression levels in microvascular endothelial cells. J Cell Biol. 2003;163:535-545. doi: 10.1083/jcb.200306001.
47. Koenen RR, Pruessmeyer J, Soehnlein O, Fraemohs L, Zernecke A, Schwarz N, Reiss K, Sarabi A, Lindbom L, Hackeng TM, Weber C, Ludwig A. Regulated release and functional modulation of junctional adhesion molecule A by disintegrin metalloproteinases. Blood. 2009;113:4799-4809. doi: 10.1182/blood-2008-04-152330.
48. Sevenich L, Bowman RL, Mason SD, Quail DF, Rapaport F, Elie BT, Brogi E, Brastianos PK, Hahn WC, Holsinger LJ, Massagué J, Leslie CS, Joyce JA. Analysis of tumour-And stroma-supplied proteolytic networks reveals a brain-metastasis-promoting role for cathepsin S. Nat Cell Biol. 2014;16:876-888. doi: 10.1038/ncb3011.
49. Rabquer BJ, Amin MA, Teegala N, Shaheen MK, Tsou PS, Ruth JH, Lesch CA, Imhof BA, Koch AE. Junctional adhesion molecule-C is a soluble mediator of angiogenesis. J Immunol. 2010;185:1777-1785. doi: 10.4049/jimmunol.1000556.
50. Mamdouh Z, Chen X, Pierini LM, Maxfield FR, Muller WA. Targeted recycling of PECAM from endothelial surface-connected compartments during diapedesis. Nature. 2003;421:748-753. doi: 10.1038/nature01300.
51. Feng G, Sullivan DP, Han F, Muller WA. Segregation of VE-cadherin from the LBRC depends on the ectodomain sequence required for homophilic adhesion. J Cell Sci. 2015;128:576-588. doi: 10.1242/jcs.159053.
52. Mamdouh Z, Kreitzer GE, Muller WA. Leukocyte transmigration requires kinesin-mediated microtubule-dependent membrane trafficking from the lateral border recycling compartment. J Exp Med. 2008;205:951-966. doi: 10.1084/jem.20072328.
53. Mamdouh Z, Mikhailov A, Muller WA. Transcellular migration of leukocytes is mediated by the endothelial lateral border recycling compartment. J Exp Med. 2009;206:2795-2808. doi: 10.1084/jem.20082745.
54. Weber EW, Han F, Tauseef M, Birnbaumer L, Mehta D, Muller WA. TRPC6 is the endothelial calcium channel that regulates leukocyte transendothelial migration during the inflammatory response. J Exp Med. 2015;212:1883-1899. doi: 10.1084/jem.20150353.
55. Watson RL, Buck J, Levin LR, Winger RC, Wang J, Arase H, Muller WA. Endothelial CD99 signals through soluble adenylyl cyclase and PKA to regulate leukocyte transendothelial migration. J Exp Med. 2015;212:1021-1041. doi: 10.1084/jem.20150354.
56. Xiao K, Garner J, Buckley KM, Vincent PA, Chiasson CM, Dejana E, Faundez V, Kowalczyk AP. p120-Catenin regulates clathrin-dependent endocytosis of VE-cadherin. Mol Biol Cell. 2005;16:5141-5151. doi: 10.1091/mbc.E05-05-0440.
57. Yan Z, Wang ZG, Segev N, Hu S, Minshall RD, Dull RO, Zhang M, Malik AB, Hu G. Rab11a mediates vascular endothelial-cadherin recycling and controls endothelial barrier function. Arterioscler Thromb Vasc Biol. 2016;36:339-349. doi: 10.1161/ATVBAHA.115.306549.
58. Nanes BA, Chiasson-MacKenzie C, Lowery AM, Ishiyama N, Faundez V, Ikura M, Vincent PA, Kowalczyk AP. p120-catenin binding masks an endocytic signal conserved in classical cadherins. J Cell Biol. 2012;199:365-380. doi: 10.1083/jcb.201205029.
59. Allingham MJ, van Buul JD, Burridge K. ICAM-1-mediated, Src-And Pyk2-dependent vascular endothelial cadherin tyrosine phosphorylation is required for leukocyte transendothelial migration. J Immunol. 2007;179:4053-4064.
60. Orsenigo F, Giampietro C, Ferrari A, et al. Phosphorylation of VE-cadherin is modulated by haemodynamic forces and contributes to the regulation of vascular permeability in vivo. Nat Commun. 2012;3:1208. doi: 10.1038/ncomms2199.
61. Gong H, Gao X, Feng S, Siddiqui MR, Garcia A, Bonini MG, Komarova Y, Vogel SM, Mehta D, Malik AB. Evidence of a common mechanism of disassembly of adherens junctions through Ga13 targeting of VE-cadherin. J Exp Med. 2014;211:579-591. doi: 10.1084/jem.20131190.
62. Frye M, Dierkes M, Küppers V, Vockel M, Tomm J, Zeuschner D, Rossaint J, Zarbock A, Koh GY, Peters K, Nottebaum AF, Vestweber D. Interfering with VE-PTP stabilizes endothelial junctions in vivo via Tie-2 in the absence of VE-cadherin. J Exp Med. 2015;212:2267-2287. doi: 10.1084/jem.20150718.
63. Giampietro C, Disanza A, Bravi L, Barrios-Rodiles M, Corada M, Frittoli E, Savorani C, Lampugnani MG, Boggetti B, Niessen C, Wrana JL, Scita G, Dejana E. The actin-binding protein EPS8 binds VE-cadherin and modulates YAP localization and signaling. J Cell Biol. 2015;211:1177-1192. doi: 10.1083/jcb.201501089.
64. Romer LH, McLean NV, Yan HC, Daise M, Sun J, DeLisser HM. IFNgamma and TNF-Alpha induce redistribution of PECAM-1 (CD31) on human endothelial cells. J Immunol. 1995;154:6582-6592.
65. Stamatovic SM, Sladojevic N, Keep RF, Andjelkovic AV. Relocalization of junctional adhesion molecule A during inflammatory stimulation of brain endothelial cells. Mol Cell Biol. 2012;32:3414-3427. doi: 10.1128/MCB.06678-11.
66. Bradfield PF, Scheiermann C, Nourshargh S, Ody C, Luscinskas FW, Rainger GE, Nash GB, Miljkovic-Licina M, Aurrand-Lions M, Imhof BA. JAM-C regulates unidirectional monocyte transendothelial migration in inflammation. Blood. 2007;110:2545-2555. doi: 10.1182/blood-2007-03-078733.
67. Ebnet K, Aurrand-Lions M, Kuhn A, Kiefer F, Butz S, Zander K, Meyer zu Brickwedde MK, Suzuki A, Imhof BA, Vestweber D. The junctional adhesion molecule (JAM) family members JAM-2 and JAM-3 associate with the cell polarity protein PAR-3: a possible role for JAMs in endothelial cell polarity. J Cell Sci. 2003;116(pt 19):3879-3891. doi: 10.1242/jcs.00704.
68. Dreymueller D, Pruessmeyer J, Groth E, Ludwig A. The role of ADAMmediated shedding in vascular biology. Eur J Cell Biol. 2012;91:472-485. doi: 10.1016/j.ejcb.2011.09.003.
69. Garton KJ, Gough PJ, Raines EW. Emerging roles for ectodomain shedding in the regulation of inflammatory responses. J Leukoc Biol. 2006;79:1105-1116. doi: 10.1189/jlb.0106038.
70. Santoso S, Sachs UJ, Kroll H, Linder M, Ruf A, Preissner KT, Chavakis T. The junctional adhesion molecule 3 (JAM-3) on human platelets is a counterreceptor for the leukocyte integrin Mac-1. J Exp Med. 2002;196:679-691.
71. Cavusoglu E, Kornecki E, Sobocka MB, Babinska A, Ehrlich YH, Chopra V, Yanamadala S, Ruwende C, Salifu MO, Clark LT, Eng C, Pinsky DJ, Marmur JD. Association of plasma levels of F11 receptor/junctional adhesion molecule-A (F11R/JAM-A) with human atherosclerosis. J Am Coll Cardiol. 2007;50:1768-1776. doi: 10.1016/j.jacc.2007.05.051.
72. Sidibé A, Mannic T, Arboleas M, Subileau M, Gulino-Debrac D, Bouillet L, Jan M, Vandhuick T, Le Loët X, Vittecoq O, Vilgrain I. Soluble VE-cadherin in rheumatoid arthritis patients correlates with disease activity: evidence for tumor necrosis factor a-induced VE-cadherin cleavage. Arthritis Rheum. 2012;64:77-87. doi: 10.1002/art.33336.
73. Zaremba J, Losy J. sPECAM-1 in serum and CSF of acute ischaemic stroke patients. Acta Neurol Scand. 2002;106:292-298.
74. Zhang RY, Liu YY, Li L, Cui W, Zhao KJ, Huang WC, Gu XW, Liu W, Wu J, Min D, Mao EQ, Tang YQ. Increased levels of soluble vascular endothelial cadherin are associated with poor outcome in severe sepsis. J Int Med Res. 2010;38:1497-1506.
75. Manetti M, Guiducci S, Romano E, Rosa I, Ceccarelli C, Mello T, Milia AF, Conforti ML, Ibba-Manneschi L, Matucci-Cerinic M. Differential expression of junctional adhesion molecules in different stages of systemic sclerosis. Arthritis Rheum. 2013;65:247-257. doi: 10.1002/art.37712.
76. Flemming S, Burkard N, Renschler M, Vielmuth F, Meir M, Schick MA, Wunder C, Germer CT, Spindler V, Waschke J, Schlegel N. Soluble VE-cadherin is involved in endothelial barrier breakdown in systemic inflammation and sepsis. Cardiovasc Res. 2015;107:32-44. doi: 10.1093/cvr/cvv144.
77. Reglero-Real N, Marcos-Ramiro B, Millán J. Endothelial membrane reorganization during leukocyte extravasation. Cell Mol Life Sci. 2012;69:3079-3099. doi: 10.1007/s00018-012-0987-4.
78. Ong KL, Leung RY, Babinska A, Salifu MO, Ehrlich YH, Kornecki E, Wong LY, Tso AW, Cherny SS, Sham PC, Lam TH, Lam KS, Cheung BM. Elevated plasma level of soluble F11 receptor/junctional adhesion molecule-A (F11R/JAM-A) in hypertension. Am J Hypertens. 2009;22:500-505. doi: 10.1038/ajh.2009.23.